IRIS
TISONE, GIUSEPPE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 75.751
EU - Europa 4.392
AS - Asia 1.529
SA - Sud America 38
Continente sconosciuto - Info sul continente non disponibili 20
OC - Oceania 12
AF - Africa 7
Totale 81.749
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 75.724
CN - Cina 1.049
UA - Ucraina 1.047
IE - Irlanda 825
DE - Germania 798
IT - Italia 497
SE - Svezia 323
KR - Corea 278
GB - Regno Unito 272
FI - Finlandia 223
RU - Federazione Russa 135
FR - Francia 132
JP - Giappone 47
IN - India 38
PL - Polonia 36
BE - Belgio 28
VN - Vietnam 25
SG - Singapore 24
CA - Canada 22
BR - Brasile 20
NL - Olanda 18
TR - Turchia 15
EU - Europa 14
AU - Australia 11
CH - Svizzera 10
CL - Cile 9
GR - Grecia 9
HK - Hong Kong 9
IR - Iran 8
ES - Italia 7
RO - Romania 7
IL - Israele 5
BG - Bulgaria 4
EG - Egitto 4
KG - Kirghizistan 4
TM - Turkmenistan 4
A1 - Anonimo 3
A2 - ???statistics.table.value.countryCode.A2??? 3
AT - Austria 3
CO - Colombia 3
DM - Dominica 3
NO - Norvegia 3
PE - Perù 3
CZ - Repubblica Ceca 2
DK - Danimarca 2
EC - Ecuador 2
HU - Ungheria 2
IQ - Iraq 2
KH - Cambogia 2
KZ - Kazakistan 2
LU - Lussemburgo 2
MD - Moldavia 2
MY - Malesia 2
NG - Nigeria 2
PT - Portogallo 2
SA - Arabia Saudita 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AM - Armenia 1
AR - Argentina 1
BD - Bangladesh 1
BZ - Belize 1
CY - Cipro 1
EE - Estonia 1
ID - Indonesia 1
JO - Giordania 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
MK - Macedonia 1
MV - Maldive 1
MX - Messico 1
NZ - Nuova Zelanda 1
PH - Filippine 1
QA - Qatar 1
TH - Thailandia 1
TN - Tunisia 1
UZ - Uzbekistan 1
Totale 81.749
Salva come PNG Salva come JPEG
Città #
Woodbridge 22.750
Wilmington 21.185
Houston 18.825
Fairfield 2.243
Ann Arbor 1.946
Chandler 1.203
Ashburn 996
Jacksonville 966
Seattle 950
Cambridge 834
Dublin 807
Medford 607
Beijing 392
Dearborn 330
Lawrence 285
Zhengzhou 281
New York 231
Rome 206
Mülheim 172
San Diego 147
Menlo Park 95
Hangzhou 82
Milan 59
San Mateo 54
Shanghai 52
Creede 51
Redwood City 51
Palo Alto 49
University Park 49
Mountain View 46
Falls Church 39
Saint Petersburg 39
Norwalk 37
London 36
Nanjing 34
Verona 33
Hefei 32
Boardman 30
Guangzhou 30
Kraków 30
Seoul 28
Engelhard 27
Brussels 25
Kunming 23
Santa Clara 21
Los Angeles 19
Helsinki 18
Nanchang 15
Hanoi 14
San Francisco 14
Indiana 12
São Paulo 12
Toronto 12
Chicago 11
Hounslow 11
Phoenix 11
Enterprise 10
Chengdu 9
Detroit 9
Dong Ket 9
Fuzhou 9
Pune 9
Washington 8
Amsterdam 7
Aydin 7
Jinan 7
Nürnberg 7
Shenzhen 7
Tokyo 7
Turin 7
Chiswick 6
Civita Castellana 6
Colorado Springs 6
Del Norte 6
Islington 6
Monmouth Junction 6
Montreal 6
New Bedfont 6
Shenyang 6
Wuhan 6
Athens 5
Baotou 5
Buffalo 5
Kilburn 5
Ningbo 5
Padova 5
Prescot 5
Simi Valley 5
Xian 5
Atlanta 4
Auburn Hills 4
Bologna 4
Changsha 4
Clearwater 4
Council Bluffs 4
Delhi 4
Groningen 4
Lorton 4
St. George 4
Yellow Springs 4
Totale 76.818
Salva come PNG Salva come JPEG
Nome #
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 489
HCV-RNA quantification in liver bioptic samples and extrahepatic compartments, using the abbott RealTime HCV assay 437
Correlation between liver fibrosis and inflammation in patients transplanted for HCV liver disease 436
Re-Evaluation of the Role of Antifibrinolytic Therapy with Lysine Analogs in Liver Transplantation in The Post-Aprotinin Era 435
Primary yolk sac tumor of the liver: incidental finding in a patient transplanted for hepatocellular carcinoma 433
Downstaging disease in patients with hepatocellular carcinoma outside up-to-seven criteria: Strategies using degradable starch microspheres transcatheter arterial chemo-embolization 433
Cyclosporine A versus tacrolimus monotherapy. Comparison on bile lipids in the first 3 months after liver transplant in humans 430
Graft failure due to hemolytic uremic syndrome recurrence 429
Operational tolerance in clinical liver transplantation: emerging developments. 429
Glycogen storage disease type Ia and VI associated with hepatocellular carcinoma: Two case reports 424
Impact of immunosuppression minimization and withdrawal in long-term hepatitis C virus liver transplant recipients 422
Is nephrectomy indicated in uremic patients with ADPKD waiting for transplant? 421
Bronchobiliary fistula treated by self-expanding ePTFE-covered nitinol stent-graft 419
Role of MRI with hepatospecific contrast agent in the identification and characterization of focal liver lesions: pathological correlation in explanted livers 419
Public epitope specificity of HLA class I antibodies induced by a failed kidney transplant: alloantibody characterization by flow cytometric techniques. 418
Relationship between GH/IGF-1 Axis, graft recovery, and early survival in patients undergoing liver transplantation 418
Hepatitis C virus recurrence and immunosuppression-free state after liver transplantation. 417
A randomized study on Peg-interferon alfa-2a with or without ribavirin in liver transplant recipients with recurrent hepatitis C. 416
Deep vein thrombosis as debut of cytomegalovirus infection associated with type ii cryoglobulinemia, with antierythrocyte specificity in a kidney transplant recipient: A case report 416
Bronchobiliary fistula treated by self-expanding ePTFE-covered nitinol stent-graft. 414
Steroid-free immunosuppression after liver transplantation does not increase the risk of graft fibrosis. 413
Complete weaning off immunosuppression in HCV liver transplant recipients is feasible and favourably impacts on the progression of disease recurrence. 413
Hepatitis B-core antibody positive donors in liver transplantation and their impact on graft survival: evidence from the Liver Match cohort study 412
Marginal donors in liver transplantation. 410
Ribavirin increases mitogen- and antigen-induced expression of CD40L on CD4+ T cells in vivo. 405
Flow cytometric analysis of antidonor-specific antibodies in liver transplant. 403
Infectious complications in renal transplant recipients 403
Conversion to rapamycin immunosuppression for malignancy after kidney transplantation 403
Treatment of hepatitis C recurrence is less successful in female than in male liver transplant recipients 403
Interposition of the right colic angle between the liver and thoracic wall: An unusual cause of massive rectal bleeding following percutaneous biopsy in a liver transplant recipient 402
Amantadine monotherapy is ineffective in the treatment of hepatitis C virus recurrence in the post-liver transplantation setting. 402
Switch to 1.5 grams MMF monotherapy for CNI-related toxicity in liver transplantation is safe and improves renal function, dyslipidemia, and hypertension 400
Quality of life and long-term follow-up after kidney transplantation: a 30-year clinical study. 400
Hepatitis C reinfection after liver transplantation in relation to virus genotype 400
Recurrence of insulin resistant metabolic syndrome following liver transplantation 399
Interposition of the right colic angle between the liver and thoracic wall: an unusual cause of massive rectal bleeding following percutaneous biopsy in a liver transplant recipient. 399
Raised hematocrit--a contributing factor to hepatic artery thrombosis following liver transplantation. 399
Everolimus with very low-exposure cyclosporine a in de novo kidney transplantation: a multicenter, randomized, controlled trial. 398
Leptin attenuates ischemia-reperfusion injury in the rat liver. 397
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies 397
Liver transplantation for Wilson's disease: The burden of neurological and psychiatric disorders 396
Graft failure due to hemolytic uremic syndrome recurrence 396
Metabolic findings after liver transplantation within a randomised trial with or without steroids 396
Extended double-dosage HBV vaccination after liver transplantation is ineffective, in the absence of lamivudine and prior wash-out of human Hepatitis B immunoglobulins 396
Management of spermatic cord liposarcoma in renal transplant recipients: case report 394
Low-dose hepatitis B immunoglobulin given "on demand" in combination with lamivudine: a highly cost-effective approach to prevent recurrent hepatitis B virus infection in the long-term follow-up after liver transplantation. 394
Gravity perfusion versus high-pressure perfusion in kidney transplantation: results from a prospective randomized study. 394
Liver abscess caused by foreign body ingestion 394
Surgical versus percutaneous technique for veno-venous bypass during orthotopic liver transplantation: a prospective randomized study. 393
Spontaneous resolution of severe acute rejection in liver transplantation. 393
Prospective study of switch from cyclosporine to tacrolimus for fibroadenomas of the breast in kidney transplantation. 393
Long-term maintenance of sustained virological response in liver transplant recipients treated for recurrent hepatitis C 393
Reduced acute rejection and side effects with neoral in liver transplantation. 393
Use of mycophenolate mofetil in liver transplantation: a literature review. 392
Extended HBV vaccination in liver transplant recipients for HBV-related cirrhosis: report of two successful cases. 391
Complete hbv prophylaxis withdrawal in HBsAg-positive liver transplant recipients after long-term minimal immunosuppression 391
Assembly of biliary lipids in native hepatic bile after orthotopic liver transplantation: a biochemical and ultra-structural study in humans 390
Clinical and neurophysiological evidence of polyneuropathy in liver transplant candidates: preliminary report. 390
Multiparameter immune profiling of operational tolerance in liver transplantation. 390
Phase I clinical trial with the AMC-bioartificial liver. 389
Liver transplantation in the presence of portal vein thrombosis: report from a single center. 389
Qualitative patterns of biliary bile acids affect cyclosporine intestinal absorption in liver transplant recipients 389
Retrospective analysis of 30 patients who underwent liver transplantation without use of steroids 389
Spontaneous resolution of severe acute rejection in liver transplantation 389
596 386
Combined liver transplantation and sleeve gastrectomy for end-stage liver disease in a bariatric patient: First European case-report 386
Safety of complete and sustained prophylaxis withdrawal in patients liver-transplanted for HBV-related cirrhosis at low risk of HBV recurrence 385
Non-transplant surgical approach to liver-based hereditary haemorrhagic telangiectasia: a first report 383
Intragastric balloon followed by biliopancreatic diversion in a liver transplant recipient: a case report. 383
Split-liver transplantation with pediatric donors: a multicenter experience. 382
Long-term, maintenance MMF monotherapy improves the fibrosis progression in liver transplant recipients with recurrent hepatitis C 382
Using transcriptional profiling to develop a diagnostic test of operational tolerance in liver transplant recipients. 380
Characterization of γδ T cell subsets in organ transplantation. 380
Is donor age a risk factor for poor graft function after orthotopic liver transplantation? 379
Ureteral obstruction in 140 renal transplant patients: preventions and treatment 379
Ab initio calcineurin inhibitor-based monotherapy immunosuppression after liver transplantation reduces the risk for Pneumocystis jirovecii pneumonia. 379
Liver transplantation for end-stage liver disease related to viral hepatitis 379
A randomized trial of everolimus and low-dose cyclosporine in renal transplantation: With or without steroids? 379
Clinical Significance of de novo production of HLA of donor-specific antibodies in kidney transplantation. 377
Endovascular treatment of giant splenic aneurysm that developed after liver transplantation. 377
Kidney transplantation and pregnancy. 376
Sequential changes in serum and biliary bile acids after liver transplantation 375
Intra-graft expression of genes involved in iron homeostasis predicts the development of operational tolerance in human liver transplantation. 374
Side-to-side caval anastomosis in a patient receiving a liver graft from a marginal donor with situs inversus totalis 374
Surgical antibiotic prophylaxis after renal transplantation: time to reconsider. 372
Improved survival in liver transplant recipients receiving prolonged-release tacrolimus in the European liver transplant registry 371
10-28 year follow-up in 23 patients with kideny traansplantation: immunosuppressive therapy, survival and complications 370
A randomized study on Peg-interferon alfa-2a with or without ribavirin in liver transplant recipients with recurrent hepatitis C 369
Average results and follow-up in 11 over-60 years of age kidney transplanted patients 369
Amantadine monotherapy is ineffective in the treatment of hepatitis C virus recurrence in the post-liver transplantation setting 367
Metabolic findings after liver transplantation within a randomised trial with or without steroids. 367
Failure of a reinforced triple course of hepatitis B vaccination in patients transplanted for HBV-related cirrhosis. 367
The Tor Vergata weaning of immunosuppression protocols in stable hepatitis C virus liver transplant patients: the 10-year follow-up 366
Liver transplantation in primary hepatic carcinoid tumor: case report and literature review. 365
2.0 J Ti:sapphire laser oscillator. 365
13C-methacetin breath test for monitoring hepatic function in cirrhotic patients before and after liver transplantation. 365
One-year pilot study on tauroursodeoxycholic acid as an adjuvant treatment after liver transplantation 364
Liver transplantation for the treatment of nodular regenerative hyperplasia 364
Post-transplant donor-specific antibody production and graft outcome in kidney transplantation: results of sixteen-year monitoring by flow cytometry. 363
Percutaneous laser ablation of hepatocellular carcinoma in patients with liver cirrhosis awaiting liver transplantation. 363
Totale 39.489
Salva come PNG Salva come JPEG
Categoria #
all - tutte 151.005
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 151.005
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20194.222 0 0 0 0 0 0 0 0 0 0 2.155 2.067
2019/202022.317 1.974 1.721 1.573 1.995 1.730 2.188 1.856 1.939 1.953 2.072 1.495 1.821
2020/202114.048 1.631 1.745 1.600 1.826 1.358 1.522 1.715 1.365 311 307 496 172
2021/20222.856 106 305 94 159 79 327 134 123 277 316 123 813
2022/20233.632 380 292 88 377 282 817 332 343 310 23 297 91
2023/20241.064 152 43 189 25 147 312 54 41 35 66 0 0
Totale 82.491